CORCEPT THERAPEUTICS INC's ticker is CORT and the CUSIP is 218352102. A total of 233 filers reported holding CORCEPT THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 0.94 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $542 | +36.2% | 19,881 | +11.2% | 0.00% | +50.0% |
| Q2 2023 | $398 | +2.8% | 17,881 | 0.0% | 0.00% | 0.0% |
| Q1 2023 | $387 | +6.6% | 17,881 | 0.0% | 0.00% | 0.0% |
| Q4 2022 | $363 | -99.9% | 17,881 | -22.1% | 0.00% | -50.0% |
| Q3 2022 | $589,000 | +7.9% | 22,960 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $546,000 | +3.8% | 22,960 | -1.7% | 0.00% | +33.3% |
| Q1 2022 | $526,000 | -4.4% | 23,360 | -15.9% | 0.00% | 0.0% |
| Q4 2021 | $550,000 | +0.7% | 27,760 | 0.0% | 0.00% | 0.0% |
| Q3 2021 | $546,000 | -10.6% | 27,760 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $611,000 | +47.9% | 27,760 | +59.9% | 0.00% | +50.0% |
| Q1 2021 | $413,000 | -9.0% | 17,360 | 0.0% | 0.00% | -33.3% |
| Q4 2020 | $454,000 | +50.3% | 17,360 | 0.0% | 0.00% | +50.0% |
| Q3 2020 | $302,000 | -48.3% | 17,360 | -50.0% | 0.00% | 0.0% |
| Q2 2020 | $584,000 | – | 34,720 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| INGALLS & SNYDER LLC | 8,370,017 | $181,295 | 9.31% |
| Novo Holdings A/S | 3,377,768 | $73,162,455 | 4.83% |
| Parallel Advisors, LLC | 3,724,573 | $80,674,251 | 2.72% |
| TANAKA CAPITAL MANAGEMENT INC | 35,539 | $770 | 2.24% |
| Shay Capital LLC | 350,000 | $7,581,000 | 1.49% |
| Shay Capital LLC | 350,000 | $7,581,000 | 1.49% |
| S&T BANK/PA | 350,924 | $7,601 | 1.37% |
| Birchview Capital, LP | 50,000 | $1,083 | 0.85% |
| Clearview Wealth Advisors LLC | 34,275 | $742,397 | 0.75% |
| Granite Investment Partners, LLC | 795,076 | $17,221,346 | 0.72% |